Improving outcomes transparency and cost/benefit in pharma and med-tech innovation.

By targeting defined data and leveraging existing evidence, artificial Intelligence (AI) and machine learning, Intacare PIE produces insights that provide early identification of existing or future outcomes risk or benefit.

PIE can also aggregate local or whole population data or insights derived from the broader Intacare knowledge pool improve outcomes analysis and identification of poor outcome risk root cause.

This enables both researchers and innovators to undertake a more powerful multidimensional analysis of trial or tech benefits assessment or outcomes risk to optimise programme benefit.